Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

64.92
Delayed Data
As of May 26
 -0.12 / -0.18%
Today’s Change
55.10
Today|||52-Week Range
66.80
+10.28%
Year-to-Date

Today’s Trading

Previous close65.04
Today’s open65.00
Day’s range64.82 - 65.21
Volume3,685,720
Average volume (3 months)9,408,340
Market cap$177.6B
Dividend yield2.90%
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.40%
Earnings growth (next 5 years)+4.70%
Revenue growth (last year)+1.86%
P/E ratio41.4
Price/Sales4.15
Price/Book4.45

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.72-0.89%
PFEPfizer-0.02-0.06%
SNYSanofi-0.03-0.06%
ABBVAbbVie-0.26-0.39%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts